Physician profile
Craig Sclar
NPI 1730114497
$7,259.08
in general payments reported to CMS, 2019-2025
58 companies · $1,305 in 2025
The $1,305 reported for 2025 was more than what 90% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,001 · 2020: $1,043 · 2021: $901 · 2022: $793 · 2023: $1,020 · 2024: $1,197 · 2025: $1,305.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,522.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,521.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $861.14 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Astrazeneca Pharmaceuticals LP | $707.41 | 2019-2025 | Wainua, Breztri, Airsupra |
| Amgen INC. | $704.59 | 2019-2025 | Repatha, Otezla, Evenity |
| Novo Nordisk INC | $570.16 | 2019-2025 | Wegovy, Rybelsus, Ozempic |
| Lilly USA, LLC | $464.48 | 2019-2025 | Mounjaro, Zepbound |
| Novartis Pharmaceuticals Corporation | $370.34 | 2019-2025 | |
| Pfizer INC. | $290.22 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $289.45 | 2019-2022 | |
| Boston Scientific Corporation | $237.49 | 2019-2024 | Watchman Access System |
| Abbvie INC. | $219.88 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $164.39 | 2022-2025 | |
| Sanofi-Aventis U.S. LLC | $160.42 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $155.92 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $146.96 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $143.47 | 2019-2025 | Xifaxan, Trulance |
Show all 58 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Craig Sclar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.